Status:
COMPLETED
Randomised Controlled Trial of a Multi-faceted Community-based Intervention to Improve Asthma in Children
Lead Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Collaborating Sponsors:
Fonds de la Recherche en Santé du Québec
GlaxoSmithKline
Conditions:
Asthma
Eligibility:
All Genders
5-17 years
Phase:
PHASE4
Brief Summary
The objectives of this trials are to demonstrate, in children with poorly controlled asthma, that an intervention to increase the awareness and the impact of poor asthma control among parents and phys...
Detailed Description
In the philosophy of the "Programs to integrate information service and manage education(PRIISME)", the proposed randomised controlled trial will examine a novel approach based on education to trigger...
Eligibility Criteria
Inclusion
- Children between 6 and 17 years of
- acute asthma requiring emergency room visit or hospital admission
- understanding of French or English
Exclusion
- the index exacerbation is the first episode of wheezing in the previous year,
- there is co-existence of other chronic pulmonary (such as Bronchopulmonary dysplasia (BPD), cystic fibrosis (CF)), renal or cardiac diseases;
Key Trial Info
Start Date :
August 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
298 Patients enrolled
Trial Details
Trial ID
NCT00238888
Start Date
August 1 2002
End Date
December 1 2011
Last Update
April 20 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ste-Justine Hospital
Montreal, Quebec, Canada, H3T 1C5